Related Experiment Videos
Antimicrobial activity of clavines.
Arzneimittel-Forschung
|January 1, 1985
Summary
Ergot alkaloids, including agroclavine and festuclavine derivatives, show significant antimicrobial activity against human pathogens. Modifications to these natural compounds also reduced their toxicity in mice.
Area of Science:
- Natural Products Chemistry
- Microbiology
- Pharmacology
Background:
- Ergot alkaloids are a class of natural compounds with diverse biological activities.
- Clavine-type alkaloids, such as agroclavine and festuclavine, are of interest for their potential therapeutic applications.
- Understanding the antimicrobial spectrum and toxicity of these compounds is crucial for drug development.
Purpose of the Study:
- To evaluate the antimicrobial activity of clavine-type ergot alkaloids and their derivatives.
- To determine the efficacy of these compounds against human pathogenic bacteria and Candida albicans.
- To assess the impact of structural modifications on the antimicrobial properties and toxicity of these alkaloids.
Main Methods:
- Antimicrobial activity was assessed using minimal inhibitory concentration (MIC) assays.
- The study tested two natural clavines (agroclavine, festuclavine) and 16 derivatives.
- Activity was evaluated against four human pathogenic bacteria and Candida albicans.
- Acute toxicity was assessed in mice.
Main Results:
- Most ergoline derivatives exhibited antibacterial properties against one to four bacterial species.
- 6-allyl-6-norfestuclavine showed potent activity against Staphylococcus aureus (MIC 30 µg/ml).
- 1-propyl-6-norfestuclavine and 6-cyano-6-norfestuclavine demonstrated broad-spectrum activity and antifungal properties.
- Structural modifications significantly reduced the acute toxicity of the natural clavines.
Conclusions:
- Clavine-type ergot alkaloids and their derivatives possess significant antimicrobial potential.
- Specific derivatives show promising activity against key human pathogens and fungi.
- Chemical modifications can enhance efficacy and reduce toxicity, paving the way for novel therapeutic agents.